Overview: Free Hemoglobin TestIntroduction: The Free Hemoglobin Test detects free hemoglobin in urine to diagnose hemolytic anemia or kidney issues, causing dark urine or fatigue. Following 2023 ASH guidelines, it uses microscopy for high specificity, aiding in hematological screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in clinical pathology for patients with suspected hemolysis or renal dysfunction.
Other Names: Hb Free Urine Assay, Urinary Hemoglobin Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Free hemoglobin testing began in the 1960s with hemolysis research. Microscopy techniques improved in the 1980s, enhancing diagnostic accuracy.
Purpose: Diagnoses hemolytic anemia or kidney issues, guides treatment, and monitors free hemoglobin in patients with dark urine or fatigue.
Test Parameters: 1. Free Hemoglobin
Pretest Condition: No fasting required. Collect urine or plasma at any time. Report symptoms like dark urine, fatigue, or jaundice, and list medications.
Specimen: 5-20 mL urine (sterile container) or 2-4 mL plasma (EDTA). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document dark urine, fatigue, jaundice, or history of hemolytic anemia or kidney disease. Include current medications, especially oxidants, and recent transfusions.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for anemia or kidney treatment.
Procedural Considerations: Uses microscopy to detect free hemoglobin in urine or plasma. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Hematuria, improper storage, or recent transfusions can affect results. Medications (e.g., oxidants) may induce false positives.
Clinical Significance: Presence of free hemoglobin suggests hemolytic anemia or kidney damage, prompting further evaluation. Negative results may require additional testing.
Specialist Consultation: Consult a hematologist or nephrologist for result interpretation and management planning.
Additional Supporting Tests: Haptoglobin, LDH, reticulocyte count, or urinalysis to confirm hemolytic anemia or kidney issues.
Test Limitations: Non-specific hemoglobin detection may occur in hematuria. Clinical correlation and additional testing are needed.
References: ASH Hemolytic Anemia Guidelines, 2023; Blood, Schrier SL, 2022.
